Taro Pharmaceutical EPS beats by $0.22, misses on revenue

Feb. 03, 2020 5:25 PM ETTaro Pharmaceutical Industries Ltd. (TARO)By: Pranav Ghumatkar, SA News Editor
  • Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22.
  • Revenue of $147.68M (-8.2% Y/Y) misses by $24.33M.
  • Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.